Last updated: August 17, 2026

Hematopoietic progenitor cells (HPCs) are the cornerstone of our blood system, responsible for the constant production of diverse blood cells essential for life. These remarkable cells bridge the gap between stem cells and mature blood cells, orchestrating the intricate process of hematopoiesis.

Hematopoietic Progenitor Cells: The Building Blocks of Blood

HPCs are a diverse group of cells characterized by their ability to self-renew and differentiate into various specialized blood cells. They reside within the bone marrow, the primary site of blood cell production in adults. HPCs are classified based on their developmental potential and the types of blood cells they can generate.

From Stem Cells to Specialized Blood Cells: The Role of Progenitors

HPCs differentiate from hematopoietic stem cells (HSCs), which possess the ultimate self-renewal capacity and the ability to generate all types of blood cells. As HPCs mature, they lose pluripotency, becoming committed to specific lineages. Common myeloid progenitors (CMPs) give rise to red blood cells, platelets, and myeloid cells, while common lymphoid progenitors (CLPs) differentiate into lymphocytes.

HPCs undergo a series of precisely regulated steps to generate mature blood cells. They first divide symmetrically, expanding the progenitor pool, and then enter asymmetric divisions, producing one progenitor cell and one committed precursor cell. Precursors undergo further maturation and differentiation to become fully functional blood cells.

Hematopoietic progenitor cells are the indispensable intermediaries in the hematopoietic process, ensuring a continuous supply of blood cells. Their ability to self-renew and differentiate into specialized lineages is crucial for maintaining blood homeostasis and responding to changing demands. Understanding the complexities of HPC biology holds immense potential for developing novel therapies for blood disorders and regenerative medicine.

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

Categories: Stem cell in Europestem cell researchstem cell therapiesStem Cell therapyStem Cell Therapy & Clinical ResearchStem Cell Treatmentstem cellsstem cells therapystem cells treatment

NBScience

contract research organization

WhatsApp